301
Views
15
CrossRef citations to date
0
Altmetric
Research Articles

Insulin resistance is increased in alopecia areata patients

, , , , &
Pages 102-106 | Received 21 Apr 2012, Accepted 14 Jul 2012, Published online: 24 Aug 2012

References

  • Alexis AF, Dudda-Subramanya R, Sinha AA. Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol 2004;14:364–370.
  • Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010;62:177–188, quiz 89–90.
  • Hordinsky M, Ericson M. Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc 2004;9:73–78.
  • Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006;20:1055–1060.
  • Sehgal VN, Bhattacharya SN, Sharma S, Srivastava G, Aggarwal AK. Alopecia areata progressing to totalis/universalis in non-insulin dependent diabetes mellitus (type II): failure of dexamethasone-cyclophosphamide pulse therapy. Indian J Dermatol Venereol Leprol 2008;74:171–173.
  • Flagothier C, Quatresooz P, Bourguignon R, Piérard-Franchimont C, Piérard GE. [Cutaneous stigmata of diabetes mellitus]. Rev Med Liege 2005;60:553–559.
  • Wang SJ, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI. Increased risk for type I (insulin-dependent) diabetes in relatives of patients with alopecia areata (AA). Am J Med Genet 1994;51:234–239.
  • Gregoriou S, Papafragkaki D, Kontochristopoulos G, Rallis E, Kalogeromitros D, Rigopoulos D. Cytokines and other mediators in alopecia areata. Mediators Inflamm 2010;2010:928030.
  • Acibucu F, Kayatas M, Candan F. The association of insulin resistance and metabolic syndrome in early androgenetic alopecia. Singapore Med J 2010;51:931–936.
  • Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol 2010;63:420–429.
  • Mumcuoglu C, Ekmekci TR, Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. Eur J Dermatol 2011;21:79–82.
  • Matilainen V, Koskela P, Keinänen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000;356:1165–1166.
  • Ekmekci TR, Ucak S, Basat O, Koslu A, Altuntas Y. The presence of insulin resistance and comparison of various insulin sensivity indices in women with androgenetic alopecia. Eur J Dermatol 2007;17:21–25.
  • González-González JG, Mancillas-Adame LG, Fernández-Reyes M, Gómez-Flores M, Lavalle-González FJ, Ocampo-Candiani J et al. Androgenetic alopecia and insulin resistance in young men. Clin Endocrinol (Oxf) 2009;71:494–499.
  • Deo SS, Mahadik SR, Chogle AR, Soneji SL, Lulla CP. Insulin sensitivity as a risk factor for common carotid intima media thickness (IMT): its relation to atherosclerosis. Clin Exp Hypertens 2007;29:445–455.
  • Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008;118:2992–3002.
  • Gysemans C, Callewaert H, Overbergh L, Mathieu C. Cytokine signalling in the beta-cell: a dual role for IFNgamma. Biochem Soc Trans 2008;36:328–333.
  • Luotola K, Pääkkönen R, Alanne M, Lanki T, Moilanen L, Surakka I et al.; Health 2000 AIRGENE Study Groups. Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis. J Clin Endocrinol Metab 2009;94:4575–4583.
  • Arca E, Musabak U, Akar A, Erbil AH, Tastan HB. Interferon-gamma in alopecia areata. Eur J Dermatol 2004;14:33–36.
  • Hoffmann R, Wenzel E, Huth A, van der Steen P, Schäufele M, Henninger HP et al. Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994;103:530–533.
  • Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Derm Venereol 1996;76:421–423.
  • Kuwano Y, Fujimoto M, Watanabe R, Ishiura N, Nakashima H, Ohno Y et al. Serum BAFF and APRIL levels in patients with alopecia areata. J Dermatol Sci 2008;50:236–239.
  • Kleemann R, Bucala R. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediators Inflamm 2010;2010:610479.
  • Shimizu T, Hizawa N, Honda A, Zhao Y, Abe R, Watanabe H et al. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun 2005;6:285–289.
  • Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80–82.
  • Shimizu T, Mizue Y, Abe R, Watanabe H, Shimizu H. Increased macrophage migration inhibitory factor (MIF) in the sera of patients with extensive alopecia areata. J Invest Dermatol 2002;118:555–557.
  • Zhang X, Yu M, Yu W, Weinberg J, Shapiro J, McElwee KJ. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol 2009;129:1527–1538.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.